However, the reluctance in adoption of rapid acting insulin due to the side effect, such as hypoglycemia, may hinder the growth of the industry. Conversely, untapped market and undiagnosed population ...

A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...

According to a Lancet study, 101 million people in India ... “Characteristically, this a effective drug that neither stimulates insulin secretion by pancreas nor acts on peripheral insulin ...

In the second phase 3 study for the combination drug, the average weight loss among the roughly 1,200 patients in the study who took CagriSema was 15.7% of their body weight after 68 weeks ...

A study published in the journal Nutrients has found that eating two cups of mango, just about 100 calories-worth, every day may help lower insulin concentration levels and improve insulin ...

Biocon said that its wholly owned subsidiary, Biocon Biologics announced strategic collaboration agreement with Civica, Inc. to expand access, affordability of Insulin Aspart in the United States.

Under the terms of the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, Inc., who will use the drug substance to produce Insulin Aspart drug product, a rapid-acting ...

A common type of diabetes medication may help cancer patients ward off the risk of heart failure by 50 per cent and boost long-term recovery, according to new research on Thursday. Heart failure ...

Agencies Biocon Share Price: This collaboration is in addition to Biocon Biologics' own insulin aspart drug product for the United States, which is currently under review by the U.S. Food and Drug ...

Under the terms of the agreement, Biocon Biologics will supply insulin aspart drug substance to Civica, who will use the drug substance to produce insulin aspart drug product, a rapid-acting insulin ...

A new study reveals that anti-obesity drugs can help kidney transplant recipients with type 2 diabetes reduce the risk of organ failure and increase survival rates. Researchers found that GLP-1 ...

The company has inked the said pact to enhance the accessibility and affordability of insulin aspart in the United States. Civica emphasizes on addressing life-saving drug shortages and slashing ...